These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21673581)

  • 21. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
    Roederer MW; Van Riper M; Valgus J; Knafl G; McLeod H
    Per Med; 2012 Jan; 9(1):19-27. PubMed ID: 29783293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences.
    Payne K; Fargher EA; Roberts SA; Tricker K; Elliott RA; Ratcliffe J; Newman WG
    Value Health; 2011 Jan; 14(1):121-34. PubMed ID: 21211494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease.
    Sychev D; Fedina L; Poptsova M; Zateyshchikov D; Mirzaev K; Tsimbal E; Sychev I; Rastvorova T
    Pharmacogenomics; 2022 Oct; 23(15):847-856. PubMed ID: 36093937
    [No Abstract]   [Full Text] [Related]  

  • 27. A systematic review of pharmacogenetic testing in primary care: Attitudes of patients, general practitioners, and pharmacists.
    Hansen JM; Nørgaard JDSV; Kälvemark Sporrong S
    Res Social Adm Pharm; 2022 Aug; 18(8):3230-3238. PubMed ID: 34996718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 29. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 30. Public perspectives about pharmacogenetic testing and managing ancillary findings.
    Haga SB; Tindall G; O'Daniel JM
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):193-7. PubMed ID: 22047505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 32. Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.
    Keeling NJ; Rosenthal MM; West-Strum D; Patel AS; Haidar CE; Hoffman JM
    Genet Med; 2019 May; 21(5):1224-1232. PubMed ID: 31048813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacy consultation for pharmacogenetic testing.
    Shin J; Kayser SR
    Per Med; 2009 Mar; 6(2):183-192. PubMed ID: 29788609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare System.
    Olander M; Waring S; Stenehjem DD; Taran A; Ranelli P; Brown JT
    Innov Pharm; 2018; 9(2):1-12. PubMed ID: 34007697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
    Crews KR; Cross SJ; McCormick JN; Baker DK; Molinelli AR; Mullins R; Relling MV; Hoffman JM
    Am J Health Syst Pharm; 2011 Jan; 68(2):143-50. PubMed ID: 21200062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
    Tang Girdwood SC; Rossow KM; Van Driest SL; Ramsey LB
    Pediatr Res; 2022 Feb; 91(3):529-538. PubMed ID: 33824446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic testing, informed consent and the problem of secondary information.
    Netzer C; Biller-Andorno N
    Bioethics; 2004 Aug; 18(4):344-60. PubMed ID: 15449406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving public views on the value of one's DNA and expectations for genomic database governance: Results from a national survey.
    Briscoe F; Ajunwa I; Gaddis A; McCormick J
    PLoS One; 2020; 15(3):e0229044. PubMed ID: 32160204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
    Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
    J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.